Atlas Trials

Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma

Clinical trial NCT07511725 · RECRUITING

Trial details

NCT number
NCT07511725
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma (GBM)
Start date
2026-01-04
Primary completion
2028-01-04
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.